Catherine Hoerth, MD
Neurology · San Francisco, CANPI 1063449866
Payments from drug & device makers
Across 41 payments — averaging $6458.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB SA$182K
- Mallinckrodt Enterprises LLC$71K
- Mallinckrodt Hospital Products Inc.$11K
- Dr.reddy's Laboratories,inc.$517
- UCB, Inc.$16
What the payments were for
- Consulting fees$51728%
- Travel & lodging$1,00355%
- Food & beverage$29516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB SA | 28 | $182,049 |
| Mallinckrodt Enterprises LLC | 8 | $70,900 |
| Mallinckrodt Hospital Products Inc. | 3 | $11,319 |
| Dr.reddy's Laboratories,inc. | 1 | $517 |
| UCB, Inc. | 1 | $16 |
How this compares
$264,800 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 206 | $2,885,173 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 31 | $424,267 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 11 | $344,448 |
| RelyvrioSod Phenylbutyrat/Taurursodiol | 26 | $312,505 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $247,750 |
| NuedextaDextromethorphan Hbr/Quinidine | 27 | $42,292 |
| Riluzole | 167 | $38,401 |
| LinzessLinaclotide | 24 | $12,796 |
| Baclofen | 96 | $6,248 |
| Glycopyrrolate | 21 | $1,171 |
| Gabapentin | 31 | $1,120 |
| Tizanidine Hcl | 17 | $741 |
| Mirtazapine | 25 | $283 |
| Trazodone Hcl | 39 | $257 |
| Diazepam | 36 | $108 |
Paid to pharmacies, not to this prescriber.
Other neurology in San Francisco
- Bruce CreeSan Francisco$8M
- Stanley PrusinerSan Francisco$6.5M
- Adam BoxerSan Francisco$5.5M
- Jennifer ClarkeSan Francisco$5.1M
- Nancy Ann Oberheim BushSan Francisco$4.6M
- Emmanuelle WaubantSan Francisco$3M
- Jill OstremSan Francisco$2M
- William JagustSan Francisco$2M
- Gil RabinoviciSan Francisco$1.9M
- Jonathan KatzSan Francisco$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.